193 related articles for article (PubMed ID: 7955103)
1. Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells.
Schrenk D; Gant TW; Michalke A; Orzechowski A; Silverman JA; Battula N; Thorgeirsson SS
Carcinogenesis; 1994 Nov; 15(11):2541-6. PubMed ID: 7955103
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of mdr genes in response to 2-acetylaminofluorene treatment in cultured rat and human hepatocytes.
Lecureur V; Guillouzo A; Fardel O
Carcinogenesis; 1996 May; 17(5):1157-60. PubMed ID: 8640928
[TBL] [Abstract][Full Text] [Related]
3. Regulation of 2-acetylaminofluorene-and 3-methylcholanthrene--mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver.
Gant TW; Silverman JA; Bisgaard HC; Burt RK; Marino PA; Thorgeirsson SS
Mol Carcinog; 1991; 4(6):499-509. PubMed ID: 1686552
[TBL] [Abstract][Full Text] [Related]
4. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene.
Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS
Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475
[TBL] [Abstract][Full Text] [Related]
5. Requirement for metabolic activation of acetylaminofluorene to induce multidrug gene expression.
Gant TW; Schrenk D; Silverman JA; Thorgeirsson SS
Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):209-12. PubMed ID: 7889850
[TBL] [Abstract][Full Text] [Related]
6. Regulation of mdr1b gene expression in Fischer, Wistar and Sprague-Dawley rats in vivo and in vitro.
Hill BA; Brown PC; Preisegger KH; Silverman JA
Carcinogenesis; 1996 Mar; 17(3):451-7. PubMed ID: 8631130
[TBL] [Abstract][Full Text] [Related]
7. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling.
Kuo MT; Liu Z; Wei Y; Lin-Lee YC; Tatebe S; Mills GB; Unate H
Oncogene; 2002 Mar; 21(13):1945-54. PubMed ID: 11960367
[TBL] [Abstract][Full Text] [Related]
8. The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice.
Møller ME; Glowinski IB; Thorgeirsson SS
Carcinogenesis; 1984 Jun; 5(6):797-804. PubMed ID: 6722987
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of P-glycoprotein expression in rat liver cells by acute doxorubicin treatment.
Fardel O; Lecureur V; Daval S; Corlu A; Guillouzo A
Eur J Biochem; 1997 May; 246(1):186-92. PubMed ID: 9210482
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone.
Schrenk D; Michalke A; Gant TW; Brown PC; Silverman JA; Thorgeirsson SS
Biochem Pharmacol; 1996 Nov; 52(9):1453-60. PubMed ID: 8937457
[TBL] [Abstract][Full Text] [Related]
12. Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes.
Kauffmann HM; Keppler D; Kartenbeck J; Schrenk D
Hepatology; 1997 Oct; 26(4):980-5. PubMed ID: 9328323
[TBL] [Abstract][Full Text] [Related]
13. Analysis of rat lymphocyte activation of benzo[a]pyrene, 2-acetylaminofluorene, and several of their metabolites to mutagenic and DNA-damaging species in vitro.
Gao N; Aidoo A; Heflich RH
Teratog Carcinog Mutagen; 1991; 11(2):65-76. PubMed ID: 1686675
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of the rat mdr1b encoded P-glycoprotein: not all inducing agents are substrates.
Santoni-Rugiu E; Silverman JA
Carcinogenesis; 1997 Nov; 18(11):2255-63. PubMed ID: 9395229
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cytotoxic and genotoxic effects of 2-acetylaminofluorene in rat and hamster hepatocytes by 3-methylcholanthrene pre-treatment.
Holme JA; Søderlund EJ; Christensen T; Trygg B; Bjørnstad C
Carcinogenesis; 1986 Sep; 7(9):1561-7. PubMed ID: 3742728
[TBL] [Abstract][Full Text] [Related]
16. Species differences in the cytotoxic and genotoxic effects of 2-acetylaminofluorene and its primary metabolites 2-aminofluorene and N-OH-2-acetylaminofluorene.
Holme JA; Søderlund EJ
Carcinogenesis; 1985 Mar; 6(3):421-5. PubMed ID: 3978756
[TBL] [Abstract][Full Text] [Related]
17. Endotoxin downregulates hepatic expression of P-glycoprotein and MRP2 in 2-acetylaminofluorene-treated rats.
Tang W; Yi C; Kalitsky J; Piquette-Miller M
Mol Cell Biol Res Commun; 2000 Aug; 4(2):90-7. PubMed ID: 11170838
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay.
Heflich RH; Djurić Z; Zhuo Z; Fullerton NF; Casciano DA; Beland FA
Environ Mol Mutagen; 1988; 11(2):167-81. PubMed ID: 3345736
[TBL] [Abstract][Full Text] [Related]
19. Effect of dexamethasone on cytochrome P-450 mediated metabolism of 2-acetylaminofluorene in cultured rat hepatocytes.
McManus ME; Edwards AM; Stupans I; Burgess W; Lucas C; Birkett DJ
Biochem Pharmacol; 1987 Jan; 36(2):237-43. PubMed ID: 2880590
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
